Antheia Secures $17 Million to Boost U.S. Production of Critical Pharmaceutical Ingredients
Antheia, a pioneering pharmaceutical ingredient manufacturer, has announced a significant $17 million funding boost aimed at transforming the supply chains of essential medicines.